FDA Inspection 1275656 — Newark Beth Israel Med Ctr IRB
The FDA completed an inspection of Newark Beth Israel Med Ctr IRB on July 2, 2025 in Newark, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 2, 2025
- Fiscal Year
- 2025
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Newark, NJ (United States)
Additional Details
IRB